The global colorectal surgery market size is anticipated to reach USD 36.6 billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of colorectal diseases, including colorectal cancer, inflammatory bowel disease (IBD), and diverticulitis, is a major driver. Colorectal cancer is one of the most common cancers globally, with the World Health Organization (WHO) reporting over 1.9 million new cases and nearly 1 million deaths in 2020. This high incidence creates a substantial demand for surgical interventions.
Technological advancements also play a crucial role. Innovations in minimally invasive surgical techniques, such as laparoscopic and robotic-assisted surgeries, have improved precision and patient outcomes, reducing recovery times and complications. The integration of advanced imaging technologies, like high-definition and 4K endoscopy, enhances diagnostic accuracy, further driving the adoption of these technologies.
Regulatory support and government initiatives are significant growth drivers as well. For example, the U.S. Preventive Services Task Force (USPSTF) recently lowered the recommended screening age for colorectal cancer to 45, increasing the demand for diagnostic and surgical procedures. Similarly, various European countries have implemented national screening programs that encourage early detection and treatment of colorectal cancer, supporting market expansion. Recent developments, such as the launch of AI-assisted endoscopy systems like Olympus' EVIS X1, are also enhancing market growth. These innovations offer real-time data and improved visualization, aiding in the early detection and treatment of colorectal conditions.
Request a free sample copy or view report summary: Colorectal Surgery Market Report
Based on product, the endoscopes segment dominated the market with a substantial share of 31.7% in 2023, driven by the increasing adoption of minimally invasive procedures, where endoscopes play a crucial role
Based on surgery type, the subtotal hemicolectomy segment held the largest revenue share of 28% in 2023
Based on indication, the colorectal cancer segment dominated the market in 2023. This is primarily attributed to the high prevalence of colorectal cancer, advancements in early detection and treatment, and significant investments in research and development
Grand View Research has segmented the global colorectal surgery market based on product, surgery type, indication, end use, and region:
Colorectal Surgery Product Outlook (Revenue, USD Million, 2018 - 2030)
Endoscopes
Electrosurgical Devices
Visual Systems & Handheld Instruments
Sealing & Stapling Devices
Ligation Clips & Dilators
Cutting Instruments (Cutters & Shears)
Surgical Accessories
Colorectal Surgery Type Outlook (Revenue, USD Million, 2018 - 2030)
Right Hemicolectomy
Left Hemicolectomy
Subtotal Hemicolectomy
Low Anterior Resection
Abdomino-Perineal Resection
Others
Colorectal Surgery Indication Outlook (Revenue, USD Million, 2018 - 2030)
Colon Polyps
Crohn's Disease
Colorectal Cancer
Colitis
Irritable Bowel Syndrome (IBS)
Others
Colorectal Surgery End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Surgery Centers
Other
Colorectal Surgery Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Colorectal Surgery Market
Intuitive Surgical.
Medtronic plc
Johnson & Johnson
Stryker Corporation
Olympus Corporation
Conmed Corporation
B. Braun SE
Karl Storz SE & Co. KG
Boston Scientific Corporation
"The quality of research they have done for us has been excellent..."